TrialReproductive biology and endocrinology : RB&E2016

Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.

Thomas Strowitzki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.